| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/26/2004 | EP1421189A2 Method and device for integrated protein expression, purification and detection |
| 05/26/2004 | EP1421117A2 Compositions and methods for generating chimeric heteromultimers |
| 05/26/2004 | EP1421116A2 Vaccine therapies and prophylactic treatments of atherosclerotic diseases |
| 05/26/2004 | EP1421115A2 Soluble t cell receptor |
| 05/26/2004 | EP1421111A2 Proteins associated with cell growth differentiation, and death |
| 05/26/2004 | EP1421103A2 Method for making acylated polypeptides |
| 05/26/2004 | EP1421102A2 Method for making acylated polypeptides |
| 05/26/2004 | EP1421098A2 Surface proteins of streptococcus pyogenes |
| 05/26/2004 | EP1420821A2 Immunologically significant herpes simplex virus antigens and methods for using same |
| 05/26/2004 | EP1420817A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 05/26/2004 | EP1127142A4 Modulation of polypeptide display on modified filamentous phage |
| 05/26/2004 | EP1083927B1 HUMAN MINOR VAULT PROTEIN p193 |
| 05/26/2004 | EP0995121B1 C-peptide specific assay procedure |
| 05/26/2004 | EP0888125B1 GLYCOSYLATED IgG ANTIBODIES |
| 05/26/2004 | EP0812331B1 Mhc-antigen complexes for detecting and purifying antigen-specific t cells |
| 05/26/2004 | EP0805851B1 Binary bac vector |
| 05/26/2004 | EP0751781B1 Use of monoclonal antibodies or soluble oligomeric ligands in the manufacture of a medicament for the prevention or treatment of neoplastic disorders |
| 05/26/2004 | CN1500147A Improved gene expression |
| 05/26/2004 | CN1500145A Method for sectetion and prodn. of protein |
| 05/26/2004 | CN1500142A High level cytokine prodn. with enhanced cell viability |
| 05/26/2004 | CN1500097A Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 05/26/2004 | CN1500095A Polymer conjugates of neublastin and methods of using ssame |
| 05/26/2004 | CN1498971A Method for expressing human recombined interleukin 18 (rhIL-18) through yeast as well as product |
| 05/26/2004 | CN1498970A Method for preparing special monoclone antibody of N type cell in human red blood cell as well as method for analyzing N type variant red blood cell |
| 05/26/2004 | CN1498902A Immune suppression fusion protein, its coded nucleic acid and application |
| 05/26/2004 | CN1498900A Anticoagulation protein of artificial threadworm as well as coding gene and method for expressing it in high efficiency |
| 05/26/2004 | CN1151268C Method for producing neurotrophon-3(NT-3) by using methanol yeast (pichia pastoris) and its application |
| 05/26/2004 | CN1151267C Method for producing human brain-derived neurotrophic factor NDNF by using methanol yeast (pichia pastoris) and its application |
| 05/26/2004 | CN1151263C Overxpression of desired proteins in eukaryotic cells mediated by cyclin D1 overexpression |
| 05/26/2004 | CN1151259C Human UMP_CMP kinase and its coding sequence, preparing process |
| 05/26/2004 | CN1151258C Prodn. of erythropoietin by endogenous gene activation |
| 05/26/2004 | CN1151173C Production process of neurotrophic factor |
| 05/26/2004 | CN1151172C Novel membrane proteine P76 of helicobacter pylori |
| 05/26/2004 | CN1151171C Recombinant syphilis spirochete epitope antigen and multiple-epitope chmeric |
| 05/26/2004 | CN1151170C Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/25/2004 | US6740744 VMP-like sequences of pathogenic borrelia |
| 05/25/2004 | US6740738 Antibodies binding to polypeptides encoded by the genes |
| 05/25/2004 | US6740526 Includes genetic recombination of plant tissue using agrobacterium |
| 05/25/2004 | US6740522 Rank (receptor activator of neurotrophic factor-kappa b) ligand (rankl) polypeptides; immunoregulatory activity |
| 05/25/2004 | US6740520 Cytokine receptor and nucleic acids encoding the same |
| 05/25/2004 | US6740509 Method for the production of mucin-type glycopeptide |
| 05/25/2004 | US6740507 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs |
| 05/25/2004 | US6740506 End selection in directed evolution |
| 05/25/2004 | US6740505 Culturing eukaryotic cells which produce proteins in a medium which comprises an alkanoic acid and/or salt at a maintained concentration |
| 05/25/2004 | US6740502 Chelation in presence of protease; bioavailability |
| 05/25/2004 | CA2260795C Synthetic protein folding catalysis |
| 05/21/2004 | WO2004042068A2 Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation |
| 05/21/2004 | WO2004042049A1 Method of degrading hardly degradable protein |
| 05/21/2004 | WO2004042003A2 Cell lysis compositions, methods of use, apparatus, and kit |
| 05/21/2004 | WO2004041193A2 HUMAN TYPE II DIABETES GENE-Kv CHANNEL-INTERACTING PROTEIN (KChIP1) LOCATED ON CHROMOSOME 5 |
| 05/21/2004 | WO2004041076A2 Methods of detecting colorectal cancer |
| 05/21/2004 | WO2004040971A1 Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof |
| 05/21/2004 | WO2004040969A1 Transgenic mammal carrying ganp and utilization thereof |
| 05/21/2004 | WO2004027049A3 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 05/21/2004 | WO2004022709A3 Epitope sequences |
| 05/21/2004 | WO2004019872A3 Oral delivery of modified transferrin fusion proteins |
| 05/21/2004 | WO2004009759A8 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 05/21/2004 | WO2003104426A3 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 05/21/2004 | WO2003080105A3 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 05/21/2004 | WO2003055440A8 Compositions and methods for the treatement of immune related diseases |
| 05/21/2004 | WO2003050275A8 Method of isolation and purification of trypsin from pronase and use thereof |
| 05/21/2004 | WO2003042362A8 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR |
| 05/21/2004 | WO2002081490A8 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| 05/21/2004 | WO2001066690A3 Novel compounds |
| 05/21/2004 | WO2000058340A3 50 human secreted proteins |
| 05/21/2004 | WO2000032745A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/21/2004 | CA2504867A1 Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof |
| 05/21/2004 | CA2504129A1 Cell lysis compositions, methods of use, apparatus, and kit |
| 05/21/2004 | CA2501523A1 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5 |
| 05/20/2004 | US20040098755 Comprises nucleotide sequences coding embryonic glycoprotein for use in the treatment and prevention of autoimmune, cell proliferative and immunological disorders; immunosuppressants; antiproliferative agents |
| 05/20/2004 | US20040097715 Recovering polypeptides which have leached from cells made porous via electric pulse |
| 05/20/2004 | US20040097713 Antibodies specific for phosphorylated insulin receptor substrate-1/2 (Ser1101/Ser1149) and uses thereof |
| 05/20/2004 | US20040097708 Comprises nucleotide sequences coding membrane protein associated with odor detection for use in biological pest control |
| 05/20/2004 | US20040097706 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/20/2004 | US20040096944 Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 05/20/2004 | US20040096940 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/20/2004 | US20040096939 Modifier of organelle metabolism |
| 05/20/2004 | US20040096938 Method for generating split, non-transferable genes that are able to express an active protein product |
| 05/20/2004 | US20040096936 Comprises nucleotide sequences coding fibroblast growth factor (FGF) for treating cardiac disorders; tissue engineering; tissue-targeted gene therapy |
| 05/20/2004 | US20040096921 Human plasma hyaluronidase |
| 05/20/2004 | US20040096901 Chineric monocllonal antibody for treatment and prevention transplant rejection, psoriasis, inflammatory bowel, autoimmune and allergic disorders |
| 05/20/2004 | US20040096888 Comprises nucleotide sequences coding cyclin dependent kinase (PELOTA) for diagnosis, treatment, prognosis and prevention of cell proliferative, cardoivascular, inflammatory, arthritic disorders |
| 05/20/2004 | US20040096877 For diagnosis/treatment/prevention of inflammation/asthma/ allergies |
| 05/20/2004 | US20040096822 HCV antigen/antibody combination assay |
| 05/20/2004 | US20040096466 Plasmodium falciparum antigens inducing protective antibodies |
| 05/20/2004 | US20040096459 Polypeptides to be administered especially to humans and in particular for therapeutic use. The polypeptide to elicit an immune response upon administration to the human subject. |
| 05/20/2004 | US20040096452 Multivalent vaccines for the treatment of B-cell malignancies (e.g., lymphomas and leukemias) . The present invention also provides methods for the production of custom vaccines, including multivalent vaccines for the treatment of immune |
| 05/20/2004 | US20040096445 Method for identifying a HLA-A2 supermotif-restricted peptide, comprising: contacting a peptide consisting of 8-11 amino acids, wherein the amino acid at position two from the N-terminus of the peptide is L, I, V, M, A, T or Q and alleles |
| 05/20/2004 | US20040096442 Modified anti-egfr antibodies with reduced immunogenicity |
| 05/20/2004 | US20040093795 Floral packaging material having great masters prints thereon |
| 05/19/2004 | EP1420032A1 Antibody recognizing gm1 ganglioside-bound amyloid beta-protein and dna encoding the antibody |
| 05/19/2004 | EP1420031A2 Bone morphogenetic protein (BMP)-18 compositions |
| 05/19/2004 | EP1419393A1 Tumor specific oligosaccharide sequences and use thereof |
| 05/19/2004 | EP1419392A1 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs |
| 05/19/2004 | EP1419264A2 Kinases and phosphatases |
| 05/19/2004 | EP1419256A2 Conjugates for the modulation of immune responses |
| 05/19/2004 | EP1419254A2 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 05/19/2004 | EP1419249A2 TIMM8b-RELATED PROTEIN |
| 05/19/2004 | EP1419242A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/19/2004 | EP1419179A2 Antigen binding domains from fish |